119 related articles for article (PubMed ID: 30899366)
41. MiR-4282 suppresses proliferation and mobility of human colorectal carcinoma cells by targeting semaphorin 3E.
Kang X; Wang M; Wang H; Shen X; Guan W
Panminerva Med; 2016 Sep; 58(3):197-205. PubMed ID: 27120047
[TBL] [Abstract][Full Text] [Related]
42. [Effects of FoxO6 on proliferation and invasion of colorectal cancer cells].
Fu Q; Cheng J; Zhang JD; Zhang YL; Chen XB; Xie JG; Luo SX
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):369-375. PubMed ID: 32482025
[No Abstract] [Full Text] [Related]
43. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
44. mTOR signaling pathway is a target for the treatment of colorectal cancer.
Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
46. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
47. [The expression and functional mechanism of long non-coding RNA LINC00339 in colorectal cancer].
Fu Q; Cheng J; Zhang JD; Zhang YL; Chen XB; Xie JG; Luo SX
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1881-1886. PubMed ID: 31269584
[No Abstract] [Full Text] [Related]
48. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC
J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727
[TBL] [Abstract][Full Text] [Related]
49. Binding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathway.
Hu B; Zhang Y; Jia L; Wu H; Fan C; Sun Y; Ye C; Liao M; Zhou J
Autophagy; 2015; 11(3):503-15. PubMed ID: 25714412
[TBL] [Abstract][Full Text] [Related]
50. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
51. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
52. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
[TBL] [Abstract][Full Text] [Related]
54. Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.
Bi J; Huang A; Liu T; Zhang T; Ma H
Int J Clin Exp Pathol; 2015; 8(6):6070-82. PubMed ID: 26261485
[TBL] [Abstract][Full Text] [Related]
55. Knockdown of biglycan expression by RNA interference inhibits the proliferation and invasion of, and induces apoptosis in, the HCT116 colon cancer cell line.
Xing X; Gu X; Ma T
Mol Med Rep; 2015 Nov; 12(5):7538-44. PubMed ID: 26459740
[TBL] [Abstract][Full Text] [Related]
56. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
57. hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer.
Chen Y; Jiang T; Shi L; He K
Med Oncol; 2016 Jan; 33(1):3. PubMed ID: 26607374
[TBL] [Abstract][Full Text] [Related]
58. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
Zhang W; Li Q; Song C; Lao L
Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
[TBL] [Abstract][Full Text] [Related]
59. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
[TBL] [Abstract][Full Text] [Related]
60. FGF14 Functions as a Tumor Suppressor through Inhibiting PI3K/AKT/mTOR Pathway in Colorectal Cancer.
Su T; Huang L; Zhang N; Peng S; Li X; Wei G; Zhai E; Zeng Z; Xu L
J Cancer; 2020; 11(4):819-825. PubMed ID: 31949485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]